Indiana | 84-2427771 | ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | ||||||
Emerging growth company | ☒ | ||||||||
• | for the election of three directors voted on by the holders of Class A common stock voting as a separate class (the “Class A Directors”) and the election of four directors voted on by the holders of Class B common stock voting as a separate class (the “Class B Directors”); |
• | with respect to any proposed “going private” transaction (as defined below) between the Company and SG Broadcasting (the holder of all the Class B common stock), or an affiliate of SG Broadcasting, or any group of which SG Broadcasting or an affiliate of SG Broadcasting is a member; and |
• | as otherwise provided by law. |
• | any individual or entity who or that, directly or indirectly, controls, is controlled by, or is under common control with SG Broadcasting; or |
• | any corporation or organization (other than MediaCo or a majority-owned subsidiary of MediaCo) of which SG Broadcasting is, directly or indirectly, the beneficial owner of 10% or more of any class of voting securities, or in which SG Broadcasting has a substantial beneficial interest. |
• | the distinctive designation of each series and the number of shares that will constitute such series; |
• | the voting rights, if any, of shares of such series; |
• | the dividend rate on the shares of such series, any restriction, limitation or condition upon the payment of such dividends, whether dividends shall be cumulative, and the dates on which dividends are payable; |
• | the prices at which, and the terms and conditions on which, the shares of such series may be redeemed, if such shares are redeemable; |
• | the purchase or sinking fund provisions, if any, for the purchase or redemption of shares of such series; |
• | any preferential amount payable upon shares of such series in the event of the liquidation, dissolution or winding-up of the company or the distribution of its assets; and |
• | the prices or rates of conversion at which, and the terms and conditions of which, the shares of such series may be converted into other securities, if such shares are convertible. |
• | one-fifth or more but less than one-third; |
• | one-third or more but less than a majority; or |
• | a majority or more. |
• | in good faith; |
• | with the care an ordinarily prudent person in a like position would exercise under similar circumstances; and |
• | in a manner the directors reasonably believe to be in the best interests of the corporation. |
• | the title of such securities; |
• | the offering price or prices and aggregate number of warrants offered; |
• | the currency or currencies for which the warrants may be purchased; |
• | if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
• | if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
• | if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time; |
• | in the case of warrants to purchase Class A common stock or preferred stock, the number of shares of Class A common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which, and the currency in which, these shares may be purchased upon such exercise; |
• | the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants; |
• | the terms of any rights to redeem or call the warrants; |
• | the terms of any rights to force the exercise of the warrants; |
• | any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
• | the dates on which the right to exercise the warrants will commence and expire; |
• | the manner in which the warrant agreements and warrants may be modified; |
• | a discussion of any material or special United States federal income tax consequences of holding or exercising the warrants; |
• | the terms of the securities issuable upon exercise of the warrants; and |
• | any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |
• | the title and aggregate number of the rights; |
• | the subscription price or a formula for the determination of the subscription price for the rights and the currency or currencies in which the subscription price may be payable; |
• | if applicable, the designation and terms of the securities with which the rights are issued and the number of rights issued with each such security or each principal amount of such security; |
• | the number or a formula for the determination of the number of the rights issued to each stockholder; |
• | the extent to which the rights are transferable; |
• | in the case of rights to purchase Class A common stock or preferred stock, the type of stock and number of shares of stock purchasable upon exercise of one right; |
• | the date on which the right to exercise the rights will commence, and the date on which the rights will expire (subject to any extension); |
• | if applicable, the minimum or maximum amount of the rights that may be exercised at any one time; |
• | the extent to which such rights include an over-subscription privilege with respect to unsubscribed securities; |
• | if applicable, the procedures for adjusting the subscription price and number of shares of Class A common stock or preferred stock purchasable upon the exercise of each right upon the occurrence of certain events, including stock splits, reverse stock splits, combinations, subdivisions or reclassifications of Class A common stock or preferred stock; |
• | the effect on the rights of any merger, consolidation, sale or other disposition of our business; |
• | the terms of any rights to redeem or call the rights; |
• | information with respect to book-entry procedures, if any; |
• | the terms of the securities issuable upon exercise of the rights; |
• | if applicable, the material terms of any standby underwriting, backstop or other purchase arrangement that we may enter into in connection with the rights offering; |
• | if applicable, a discussion of certain U.S. federal income tax considerations; and |
• | any other terms of the rights, including terms, procedures and limitations relating to the exchange and exercise of the rights. |
• | the designation and terms of the units and the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; |
• | any provision for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and |
• | whether the units will be issued in fully registered or global form. |
• | at a fixed price or prices, which may be changed; |
• | at market prices prevailing at the time of sale; |
• | at prices related to such prevailing market prices; |
• | at varying prices determined at the time of sale; or |
• | at negotiated prices. |
• | on or through the facilities of The Nasdaq Capital Market or any other securities exchange or quotation or trading service on which such securities may be listed, quoted or traded at the time of sale; and/or |
• | to or through a market maker otherwise than on The Nasdaq Capital Market or such other securities exchanges or quotation or trading services. |
• | the name or names of any underwriters, dealers or agents participating in the offering, if any; |
• | the purchase price of the securities sold by us to any underwriter or dealer and the net proceeds we expect to receive from the offering; |
• | any option, under which underwriters may purchase additional securities from us; |
• | any agency fees or underwriting discounts or commissions and other items constituting agents’ or underwriters’ compensation; |
• | any public offering price; |
• | any discounts or concessions allowed or reallowed or paid to dealers; and |
• | any securities exchange or market on which the securities may be listed. |
1. | our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on April 1, 2024 (as amended by Amendment No. 1 thereto, filed with the SEC on April 29, 2024); |
2. | our Quarterly Reports on Form 10-Q for the fiscal quarter ended March 31, 2024, filed with the SEC on May 15, 2024, for the fiscal quarter ended June 30, 2024, filed with the SEC on September 18, 2024 and for the fiscal quarter ended September 30, 2024, filed with the SEC on November 14, 2024; |
3. | our Current Reports on Form 8-K filed with the SEC on March 15, 2024, April 10, 2024, April 18, 2024 (as amended on July 3, 2024 and November 22, 2024), July 11, 2024, August 21, 2024 (but excluding Item 7.01 and Exhibit 99.1), September 16, 2024, September 23, 2024, September 27, 2024 (as amended on October 7, 2024) and October 30, 2024 (but excluding Item 7.01 and Exhibit 99.1); and |
4. | the description of the Class A common stock of the Registrant contained in a registration statement on Form 10 filed under the Exchange Act on November 1, 2019 (as amended on November 8, 2019, November 15, 2019 and November 22, 2019) and declared effective by the Commission on November 26, 2019, as supplemented by the “Description of Capital Stock” included in this prospectus and including any amendment or report filed for the purpose of updating such description. |
Item 14. | Other Expenses of Issuance and Distribution |
SEC registration fee | —(1) | ||
Legal fees and expenses | (2) | ||
Accounting fees and expenses | (2) | ||
Transfer agent and registrar fees and expenses | (2) | ||
Stock exchange listing fees | (2) | ||
Printing, FINRA filing fee (if applicable) and miscellaneous expenses | (2) | ||
Total | (2) | ||
(1) | Excludes the registration fee previously paid in connection with unsold securities pursuant to Rule 415(a)(6). Please see Exhibit 107 to this registration statement for more information. |
(2) | These fees will be dependent on the number and amount of securities offerings under this registration statement and, therefore, cannot be estimated at this time. In accordance with Rule 430B, additional information regarding estimated fees and expenses will be provided at the time information as to an offering is included in a prospectus supplement. |
Item 15. | Indemnification of Directors and Officers |
Item 16. | Exhibits |
Exhibit Number | Document | ||
1.1* | Form of Underwriting Agreement. | ||
4.2* | Form of Preferred Stock Certificate. | ||
4.3* | Form of Certificate of Designation of Preferred Stock. | ||
4.4* | Form of Warrant Agreement. | ||
4.5* | Form of Warrant Certificate. | ||
4.6* | Form of Rights Certificate. | ||
4.7* | Form of Unit Agreement. | ||
4.8* | Form of Unit Certificate. | ||
Consent of BDO USA, P.C. | |||
Powers of Attorney. | |||
Filing fee table. | |||
* | To be filed by amendment or as an exhibit to a document filed under the Exchange Act, and incorporated by reference herein. |
** | Filed herewith. |
+ | Previously filed. |
Item 17. | Undertakings |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement; |
(2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |
(i) | Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
(ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which the prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of this registration statement or made in a document incorporated or deemed incorporated by reference into this registration statement or prospectus that is a part of this registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in this registration statement or prospectus that was part of this registration statement or made in any such document immediately prior to such effective date. |
(5) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
(6) | That, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(7) | If and when applicable, to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act. |
MEDIACO HOLDING INC. | ||||||
By: | /s/ Alberto Rodriguez | |||||
Alberto Rodriguez | ||||||
Interim Chief Executive Officer and President | ||||||
Signature | Title | Date | ||||
/s/ Alberto Rodriguez | Interim Chief Executive Officer and President (principal executive officer) | November 22, 2024 | ||||
Alberto Rodriguez | ||||||
/s/ Debra DeFelice | Chief Financial Officer and Treasurer (principal financial and accounting officer) | November 22, 2024 | ||||
Debra DeFelice | ||||||
* | Chair of Board of Directors | November 22, 2024 | ||||
Deborah A. McDermott | ||||||
* | Director | November 22, 2024 | ||||
Colbert Cannon | ||||||
* | Director | November 22, 2024 | ||||
J. Scott Enright | ||||||
* | Director | November 22, 2024 | ||||
Andrew Glaze | ||||||
* | Director | November 22, 2024 | ||||
Robert L. Greene | ||||||
/s/ Jacqueline Hernández | Director | November 22, 2024 | ||||
Jacqueline Hernández | ||||||
* | Director | November 22, 2024 | ||||
Mary Beth McAdaragh | ||||||
* | Director | November 22, 2024 | ||||
Brett Pertuz | ||||||
* | Director | November 22, 2024 | ||||
Jeffrey H. Smulyan | ||||||
* | Director | November 22, 2024 | ||||
Amit Thakrar | ||||||
* | Director | November 22, 2024 | ||||
Patrick M. Walsh | ||||||
*By: | /s/ Jacqueline Hernández | ||
Jacqueline Hernández | |||
Attorney-in-fact | |||